Leap Therapeutics, a Nasdaq-listed company, has invested $18 million in Zcash (ZEC), acquiring 29,869 tokens at an average price of $602.63 each. This purchase increases their total ZEC holdings to 232,644 tokens. The investment signals a growing institutional interest in privacy-focused cryptocurrencies and highlights Leap Therapeutics' confidence in Zcash's technology and potential for long-term value.